J&J-Guidant Deal Could Aid Boston Scientific -Analysts
21679
The anticipated merger of Guidant Corp.  and Johnson & Johnson could give an unintended boost to Boston  Scientific Corp. if Guidant's drug-coated stent launch is  delayed, said analysts looking at the implications of a  potential deal.
670784
NEW YORK - US health titan Johnson and Johnson is in &quot;advanced negotiations&quot; for a 24-billion-dollar takeover of US heart device manufacturer Guidant, the New York Times said.
199086
Johnson & Johnson has agreed to  buy Guidant Corp. for $25.4 billion in cash and stock, the  companies said on Wednesday, giving the healthcare products  maker a foothold in the fast-growing market for implantable  devices that regulate heartbeats.
570795
Health care and consumer products maker Johnson & Johnson  on Sunday was close to finalizing details of a &#36;24 billion cash and stock acquisition of medical-device maker Guidant Corp. , according to people familiar with the matter.
739833
U.S. blue chips rose  on Thursday,  boosted by Johnson & Johnson JNJ.N following its move to buy  Guidant Corp. GDT.N, but market gains were limited after  Goldman Sachs posted disappointing revenues.
462708
Health care and consumer products maker Johnson &amp; Johnson is close to finalizing its long-rumored $24 billion cash and stock acquisition of medical-device maker Guidant Corp.
152488
Goldman Sachs analyst Sarah Friar was upbeat on a potential combination of the two companies, although some other analysts took a more guarded stance on the potential merger.
388933
Washington - United States health titan Johnson and Johnson has reached a deal to acquire American heart device manufacturer Guidant, in a stock-and-cash deal valued at $23.9-billion, based on $76 per share, the companies said in a statement early on
340033
Johnson & Johnson is in advanced negotiations to acquire Guidant, one of the nation's largest makers of devices to treat heart illnesses, for more than $24 billion.
680919
Johnson &amp; Johnson, the maker of Band- Aids and other products, is in talks to buy Guidant Corp. for more than $24 billion, the New York Times reported, citing unidentified executives familiar with the talks.
429216
Drug giant Johnson & Johnson is working on a $24bn purchase of medical device firm Guidant Corp, a key player in the heart technology market.
759956
Johnson & Johnson aims to seal a purchase of Guidant Corp. without immediately jettisoning the medical device maker's stent operations, sources familiar with the situation said on Thursday.
95065
Credit Suisse First Boston maintained &quot;neutral&quot; ratings on Guidant (nyse: GDT - news - people ) and Johnson &amp; Johnson (nyse: JNJ - news - people ), saying a near-term acquisition of the former by the latter values Guidant at $76.
336391
U.S. blue chips closed slightly higher  on Thursday, helped by Johnson & Johnson Inc.'s JNJ.N $25  billion deal to buy Guidant Corp. GDT.N, but the broader  market fell, with Goldman Sachs Group Inc. GS.N dragging the  S&P 500 lower after posting quarterly revenues that  disappointed Wall Street.
584943
Johnson & Johnson  has sued  Boston Scientific  and Abbott Laboratories Inc. ,  seeking at least $5.5 billion in damages related to J&J's  failed bid to acquire medical device maker Guidant Corp.
179502
Shares of medical device maker Guidant  Corp.GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
667986
U.S. stocks were little changed on  Tuesday, with oil prices dropping below $42 a barrel helping to  support markets, but Johnson & Johnson JNJ.N put pressure on  the Dow following a report of a possible $24 billion takeover  of cardiovascular device maker Guidant Corp. GDT.N.